TrialBritish journal of clinical pharmacology2018

A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL-1401O vs. EU-trastuzumab and US-trastuzumab.

Cornelius F Waller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.